Jeffrey Smith

Jeffrey Smith

Central US Merck & Co., Inc. - / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 5696213
person_outline Jeffrey Smith's MOST POPULAR ARTICLES
1-) Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection npj Vaccines 5 (1), 16, 2020
2-) A tetravalent sub-unit dengue vaccine formulated with ionizable cationic lipid nanoparticle induces significant immune responses in rodents and non-human primates Scientific reports 6 (1), 34215, 2016
3-) Mechanism of macromolecular structure evolution in self-assembled lipid nanoparticles for siRNA delivery Langmuir 30 (16), 4613-4622, 2014
4-) PKA catalytic subunit compartmentation regulates contractile and hypertrophic responses to β-adrenergic signaling Journal of molecular and cellular cardiology 66, 83-93, 2014
5-) Antibody responses to crucial functional epitopes as a novel approach to assess immunogenicity of vaccine adjuvants Vaccine 37 (29), 3770-3778, 2019